SARS-CoV-2 variant detection and identification
Effective genomic surveillance of SARS-CoV-2 variants begins with the right tools
Great product with high quality results
Used for qualitative detection of specific SARS-CoV-2 mutations
Easy to understand the instructions. SARS-CoV-2 Variant ValuPanel™ assays gives highly specific and quality results. Highly recommended
Review Date: 11 Sept 2021 | LGC Biosearch Technologies
Emerging SARS-CoV-2 variants will require global monitoring to ensure diagnostic tests, vaccines, and other antiviral therapies remain effective. As the virus’ mutations change its transmissibility and/or severity, public health control measures can stay ahead of the curve by analysing a subset of positive COVID-19 patient samples. These genomic surveillance programs include genotyping and sequencing the mutations, which can help characterise known variants and discover novel variants.
How to choose a molecular diagnostics supplier
In this guide, LGC, Biosearch Technologies, provides a streamlined approach to choosing an experienced supplier for your molecular diagnostics components, including:
- Key questions for your internal team to identify supply needs for current R&D and future commercialization
- A process for researching and evaluating potential supply partners
- Tips for managing a strong and dynamic relationship with your supplier
Is it really negative? The importance of using accurate metrics for COVID-19 diagnosis
As the WHO set guidelines for measuring COVID-19 viral loads during clinical diagnosis, one research group challenged the accuracy of this metric (and provided a better alternative)
The need for reproducible and standardized metrics for SARS-CoV-2: What we learned from COVID-19
Even though viral measurements are fairly standardized, a different metric was used to quantify SARS-CoV-2. Read how one research team investigated this disparity
SARS-CoV-2 variants: Are Ct values an unused piece of the profiling puzzle?
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative
Keeping up with COVID-19: Designing novel monitoring assays to tackle the rise of variants
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
Product Overview
Links
Products Model Information
SARS-CoV-2 Variant ValuPanel™ assays
LGC Biosearch TechnologiesSARS-CoV-2 Variant ValuPanel™ assays consist of separately delivered probes and primers that are designed for qualitative detection of specific SARS-CoV-2 mutations by genotyping using reverse transcription-polymerase chain reaction (RT-PCR).























